Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1962 Oct;41(10):1915–1921. doi: 10.1172/JCI104648

SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD*

P J Nestel 1,†, R J Havel 1,‡, A Bezman 1,§
PMCID: PMC291116  PMID: 16695884

Full text

PDF
1919

Images in this article

1916Image
on p.1916
1916Image
on p.1916
1916Image
on p.1916
1916Image
on p.1916

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BORGSTROM B., JORDAN P. Metabolism of chylomicron glyceride as studied by C14-glycerol-C14-palmitic acid labeled chylomicrons. Acta Soc Med Ups. 1959;64:185–193. [PubMed] [Google Scholar]
  2. BRAGDON J. H., GORDON R. S., Jr Tissue distribution of C14 after the intravenous injection of labeled chylomicrons and unesterified fatty acids in the rat. J Clin Invest. 1958 Apr;37(4):574–578. doi: 10.1172/JCI103640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CARLSON L. A. Determination of serum glycerides. Acta Soc Med Ups. 1959;64:208–213. [PubMed] [Google Scholar]
  4. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FRASER J. R., LOVELL R. R., NESTEL P. J. The production of lipolytic activity in the human forearm in response to heparin. Clin Sci. 1961 Jun;20:351–356. [PubMed] [Google Scholar]
  6. FREDRICKSON D. S., HAVEL R. J. The metabolism of chylomicra. I. The removal of palmitic acid-1-C14 labeled chylomicra from dog plasma. J Clin Invest. 1956 Sep;35(9):1025–1032. doi: 10.1172/JCI103348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FREDRICKSON D. S., McCOLLESTER D. L., ONO K. The role of unesterified fatty acid transport in chylomicron metabolism. J Clin Invest. 1958 Oct;37(10):1333–1341. doi: 10.1172/JCI103722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FRENCH J. E., MORRIS B. The removal of 14C-labelled chylomicron fat from the circulation in rats. J Physiol. 1957 Sep 30;138(2):326–339. doi: 10.1113/jphysiol.1957.sp005854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. FRENCH J. E., MORRIS B. The tissue distribution and oxidation of 14C-labelled chylomicron fat injected intravenously in rats. J Physiol. 1958 Feb 17;140(2):262–271. doi: 10.1113/jphysiol.1958.sp005932. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KORN E. D. Clearing factor, a heparin-activated lipoprotein lipase. I. Isolation and characterization of the enzyme from normal rat heart. J Biol Chem. 1955 Jul;215(1):1–14. [PubMed] [Google Scholar]
  11. ROBINSON D. S., HARRIS P. M. The production of lipolytic activity in the circulation of the hind limb in response to heparin. Q J Exp Physiol Cogn Med Sci. 1959 Jan;44(1):80–90. doi: 10.1113/expphysiol.1959.sp001378. [DOI] [PubMed] [Google Scholar]
  12. STEIN Y., SHAPIRO B. Assimilation and dissimilation of fatty acids by the rat liver. Am J Physiol. 1959 Jun;196(6):1238–1241. doi: 10.1152/ajplegacy.1959.196.6.1238. [DOI] [PubMed] [Google Scholar]
  13. VAN HANDEL E., ZILVERSMIT D. B. Limitation of radioiodine as a label for fat. J Lab Clin Med. 1958 Dec;52(6):831–839. [PubMed] [Google Scholar]
  14. ZILVERSMIT D. B. The design and analysis of isotope experiments. Am J Med. 1960 Nov;29:832–848. doi: 10.1016/0002-9343(60)90117-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES